STTCOMP OSL TA LONG
Market Cap: $40.27 Million
Share Price: $0.009
Shares: 4,474 Million
Overview
OncoSil Medical Limited (OSL) is an ASX-listed medical device company with a focus on localised treatments for patients with pancreatic and liver cancer. The company's lead product, OncoSil, is a medical device that delivers targeted radioactive isotope (Phosphorous-32) directly into a patient's pancreatic tumours via an endoscopic ultrasound. This treatment, known as brachytherapy, is intended to deliver more concentrated and localized radiation. Over the past year, the company has made significant progress in its operations, including the first commercial treatment of the OncoSil device in Europe..
